Literature DB >> 11489279

Congenital glioblastoma multiforme: a report of three cases and a review of the literature.

J L Winters1, D Wilson, D G Davis.   

Abstract

The clinical histories, histologic features, and immunohistochemical staining patterns for glial fibrillary acidic protein, vimentin, p53, and epidermal growth factor receptor (EGFR) of three cases of congenital glioblastoma multiforme are given and previous case reports are reviewed. Of the three cases reported in this series, two have had long-term survivals of greater than 2 1/2 and 5 1/2 years after surgery and surgery followed by chemotherapy, respectively. Both of these cases also demonstrated p53 protein accumulation, a finding in pediatric glioblastoma multiforme associated with poor prognosis. The third case occurred in an infant who died at birth and demonstrated a well-circumscribed tumor that did not invade adjacent brain parenchyma. Considering these three cases, the biological behavior in congenital glioblastoma multiforme may not be unfavorable as portrayed in the literature or as seen in its adult counterpart.

Entities:  

Mesh:

Year:  2001        PMID: 11489279     DOI: 10.1016/s0022-510x(01)00538-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  18 in total

1.  Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival.

Authors:  Chiagozie Ononiwu; Vivek Mehta; Chetan Bettegowda; George Jallo
Journal:  Childs Nerv Syst       Date:  2012-02-04       Impact factor: 1.475

2.  Congenital brain tumors in a series of 56 patients.

Authors:  Elżbieta Jurkiewicz; Agnieszka Brożyna; Wiesława Grajkowska; Monika Bekiesińska-Figatowska; Paweł Daszkiewicz; Katarzyna Nowak; Katarzyna Malczyk; Jerzy Walecki; Danuta Perek; Małgorzata Syczewska
Journal:  Childs Nerv Syst       Date:  2012-05-31       Impact factor: 1.475

3.  A report of nine newborns with congenital brain tumours.

Authors:  Henrik Carstensen; Marianne Juhler; Lars Bøgeskov; Henning Laursen
Journal:  Childs Nerv Syst       Date:  2006-06-28       Impact factor: 1.475

4.  Clinical and molecular characteristics of congenital glioblastoma.

Authors:  Margaret E Macy; Diane K Birks; Valerie N Barton; Michael H Chan; Andrew M Donson; B K Kleinschmidt-Demasters; Lynne T Bemis; Michael H Handler; Nicholas K Foreman
Journal:  Neuro Oncol       Date:  2012-06-18       Impact factor: 12.300

5.  Congenital glioblastoma multiforme with abnormal vascularity presenting as intracranial hemorrhage in prenatal ultrasound.

Authors:  Manfred Sell; Sabine Huber-Schumacher; Frank K H van Landeghem
Journal:  Childs Nerv Syst       Date:  2006-05-04       Impact factor: 1.475

6.  Distinct survival and clinical profile of infantile glioblastoma: insights from a national database.

Authors:  Victor M Lu; Daniel G Eichberg; Evan M Luther; Ashish H Shah; David J Daniels; Ossama M Maher; Toba N Niazi
Journal:  Childs Nerv Syst       Date:  2021-10-13       Impact factor: 1.475

Review 7.  Paediatric spinal glioblastoma: case report and review of therapeutic strategies.

Authors:  Philip J O'Halloran; Michael Farrell; John Caird; Michael Capra; David O'Brien
Journal:  Childs Nerv Syst       Date:  2013-01-15       Impact factor: 1.475

8.  A case of definitely congenital glioblastoma manifested by intratumoral hemorrhage.

Authors:  Norihito Shimamura; Ken-Ichiroh Asano; Kazumi Ogane; Akinori Yagihashi; Hiroki Ohkuma; Shigeharu Suzuki
Journal:  Childs Nerv Syst       Date:  2003-09-13       Impact factor: 1.475

9.  Prenatal diagnosis of a giant congenital primary cerebral hemangiopericytoma.

Authors:  Gábor Sobel; Judit Halász; Katalin Bogdányi; István Szabó; Katalin Borka; Péter Molnár; Zsuzsa Schaff; Ferenc Paulin; Ferenc Bánhidy
Journal:  Pathol Oncol Res       Date:  2006-03-23       Impact factor: 3.201

10.  Congenital diffuse anaplastic astrocytoma with ependymal and leptomeningeal spread: case report.

Authors:  A M Stark; S Modlich; A Claviez; A van Baalen; H-H Hugo; H M Mehdorn
Journal:  J Neurooncol       Date:  2007-04-19       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.